English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [527]
News [1939]
Articles [129]
Editorials [6]
Conferences [59]
elearning [17]
Listeria-based booster improves vaccine’s protection against recurring colon cancer
Listeria-based booster improves vaccine’s protection against recurring colon cancer
Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-related toxin
Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-rela...
ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvironment and response to immunotherapy across cancer types
ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvi...
Screening and removal of precancerous lesions prevents anal cancer
Screening and removal of precancerous lesions prevents anal cancer
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
How diet and the microbiome affect colorectal cancer
How diet and the microbiome affect colorectal cancer
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic col...
ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer
ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer
Exercise amplifies immune attack on pancreatic cancer
Exercise amplifies immune attack on pancreatic cancer
<12345...194>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307